252 related articles for article (PubMed ID: 28689321)
101. Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules.
Bakkar S; Macerola E; Proietti A; Aljarrah Q; Al-Omar K; Materazzi G; Basolo F; Miccoli P
Updates Surg; 2021 Feb; 73(1):281-288. PubMed ID: 32410160
[TBL] [Abstract][Full Text] [Related]
102. Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations.
Pandya A; Caoili EM; Jawad-Makki F; Wasnik AP; Shankar PR; Bude R; Haymart MR; Davenport MS
J Clin Endocrinol Metab; 2018 Sep; 103(9):3496-3502. PubMed ID: 29982716
[TBL] [Abstract][Full Text] [Related]
103. Systematic differences between ultrasound and pathological evaluation of thyroid nodules: a method comparison study.
Chew CR; Lam T; Chan STF; Chin-Lenn L
ANZ J Surg; 2018 May; 88(5):464-467. PubMed ID: 28608502
[TBL] [Abstract][Full Text] [Related]
104. Need for Completion Thyroidectomy in Patients Undergoing Lobectomy for Indeterminate and High-Risk Nodules: Impact of Intra-Operative Findings and Final Pathology.
Moore EC; Zolin S; Krishnamurthy V; Jin J; Shin J; Berber E; Siperstein A
World J Surg; 2020 Feb; 44(2):408-416. PubMed ID: 31531727
[TBL] [Abstract][Full Text] [Related]
105. Isthmectomy: a conservative operation for solitary nodule of the thyroid isthmus.
Pérez-Ruiz L; Ros-López S; Gudelis M; Latasa-Gimeno JA; Artigas-Marco C; Pelayo-Salas A
Acta Chir Belg; 2008; 108(6):699-701. PubMed ID: 19241921
[TBL] [Abstract][Full Text] [Related]
106. Positive Correlation of Thyroid Nodule Cytology with Molecular Profiling-a Single-Center Experience.
Tessler I; Shochat I; Cohen O; Meir A; Avior G
Endocr Pathol; 2021 Dec; 32(4):480-488. PubMed ID: 34086262
[TBL] [Abstract][Full Text] [Related]
107. Thyroid Nodule Shape Independently Predicts Risk of Malignancy.
Pappa T; Ahmadi S; Bikas A; Hwang S; Coleman A; Lobon I; Xiang P; Kim M; Marqusee E; Richman DM; Durfee SM; Asch EH; Benson CB; Frates MC; Landa I; Alexander EK
J Clin Endocrinol Metab; 2022 Jun; 107(7):1865-1870. PubMed ID: 35439309
[TBL] [Abstract][Full Text] [Related]
108. Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease.
Elshaer RK; Halawa MR; Ahmed IZ; Aboelezz NF; Mohamed NR; Bahaa Eldin AM
Egypt J Immunol; 2022 Oct; 29(4):156-162. PubMed ID: 36208044
[TBL] [Abstract][Full Text] [Related]
109. A pragmatic assessment of the British Thyroid Association "U classification" of thyroid nodules with a focus on their follow-up.
Arambewela MH; Wijesinghe AM; Randhawa K; Bull M; Wadsley J; Balasubramanian SP
Clin Radiol; 2020 Jun; 75(6):466-473. PubMed ID: 32184000
[TBL] [Abstract][Full Text] [Related]
110. FNAC and Its Utility in Solitary Thyroid Nodule and Its Correlation with Histopathological Examination.
Momin MA; Bhuiyan FU; Chakraborty S; Kar NK
Mymensingh Med J; 2019 Apr; 28(2):356-363. PubMed ID: 31086151
[TBL] [Abstract][Full Text] [Related]
111. Multinodular goiter: A study of malignancy risk in nondominant nodules.
Yong JS; Loh KS; Petersson BF; Thong M
Ear Nose Throat J; 2017 Aug; 96(8):336-342. PubMed ID: 28846789
[TBL] [Abstract][Full Text] [Related]
112. A Prospective Observational Study Assessing the Relationship Between Solitary Thyroid Nodule Size and Incidence of Malignancy.
Monib S; Farkas N; Abdelaziz MI
Cureus; 2020 Nov; 12(11):e11422. PubMed ID: 33312818
[TBL] [Abstract][Full Text] [Related]
113. Is there a relationship between preoperative cytological diagnosis and evolution in patients with differentiated thyroid carcinoma? A retrospective study.
Colenci R; Minicucci MF; Soares CSP; de Oliveira CC; de Alencar Marques ME; Tagliarini JV; da Silva Mazeto GMF
Arch Endocrinol Metab; 2022 Apr; 66(2):237-246. PubMed ID: 35420266
[TBL] [Abstract][Full Text] [Related]
114. Diagnostic thyroid lobectomy versus active surveillance in the management of Bethesda class III thyroid nodules.
Goh X; Ting Y; Nga ME; Lim LC; Lim CM
Asian J Surg; 2020 Nov; 43(11):1108-1109. PubMed ID: 32998834
[No Abstract] [Full Text] [Related]
115. TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.
Alaraifi AK; Alessa M; Hijazi LO; Alayed AM; Alsalem AA
Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):183-188. PubMed ID: 37204842
[TBL] [Abstract][Full Text] [Related]
116. Nodule and cancer assessment following thyroid surgery: a cohort of 460 patients.
Aslan F; Alyanak A
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9565-9570. PubMed ID: 33015799
[TBL] [Abstract][Full Text] [Related]
117. Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region.
Loderer T; Bonati E; Donato V; Viani L; Cozzani F; Del Rio P
Gland Surg; 2023 Jul; 12(7):884-893. PubMed ID: 37727346
[TBL] [Abstract][Full Text] [Related]
118. Follow-up of large thyroid nodules without surgery: Patient selection and long-term outcomes.
Cohen O; Zornitzki T; Yarkoni TR; Lahav Y; Schindel D; Halperin D; Yehuda M
Head Neck; 2019 Jun; 41(6):1696-1702. PubMed ID: 30694007
[TBL] [Abstract][Full Text] [Related]
119. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract][Full Text] [Related]
120. [Approach to cytologically-benign recurrent thyroid cysts].
Pla-Martí V; Fernández-Martínez C; Pallas-Regueira A; Rodríguez-Carrillo R; Ibáñez-Arias A; Flors-Alandí C; Roig-Vila JV
Cir Esp; 2005 May; 77(5):267-70. PubMed ID: 16420932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
